Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ibandronic acid + natural eggshell membrane
- Development stage
- Unknown
- Lead developer
- anwerina Deutschland
- Modality
- Peptides, Small Molecules
- Administration
- Oral
01
Overview
Bonviva + OsteoStix NEM is a combination product marketed by anwerina Deutschland, primarily indicated for the treatment of postmenopausal osteoporosis. The product combines **Bonviva**, which contains the active pharmaceutical ingredient **ibandronic acid**, with **OsteoStix NEM**, a supplement containing **Natural Eggshell Membrane (NEM)**. Ibandronic acid is a nitrogen-containing bisphosphonate that acts by inhibiting farnesyl pyrophosphate synthase within osteoclasts, thereby reducing bone resorption and increasing bone mineral density. Natural Eggshell Membrane is a dietary ingredient rich in collagen, glycosaminoglycans (such as chondroitin sulfate and hyaluronic acid), and proteins, intended to provide nutritional support for bone matrix and joint health. The combination aims to provide both pharmacological inhibition of bone loss and structural support for the skeletal system.
- Brand names
- Bonviva + OsteoStix NEM
- Other names
- BonvivaOsteoStix NEMibandronate + natural eggshell membrane
02
Targets
FDPS (Farnesyl pyrophosphate synthase)HA (Hemagglutinin)
Beyond the preview
Go deeper on ibandronic acid + natural eggshell membrane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ibandronic acid + natural eggshell membrane.